Delivery Order SPE2D021DA002-SPE2D325F094F
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,181.70 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025. The contract calls for the delivery of ENGERIX-B 20 MCG/ML syringes, a hepatitis B vaccine, with an ultimate completion date of August 14, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,575.60 for ENGERIX-B 20 mcg/ml syringes by the Defense Logistics Agency's Medical Supply Chain on July 14, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 17, 2025, will be performed at the awardee's Park Ridge location. The contract was awarded without a set-aside designation, and represents a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,969.50 by the Defense Logistics Agency's Medical Supply Chain on September 10, 2025, with an ultimate completion date of September 15, 2025. The delivery order covers ENGERIX-B 20 micrograms per milliliter in syringe format, a hepatitis B vaccine commonly administered to military personnel and federal healthcare...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $2,757.30 on July 15, 2025, for the supply of ENGERIX-B 20 MCG/ML syringes. The award, which carries an ultimate completion date of July 18, 2025, was issued without a set-aside designation and is funded through the Defense Logistics Agency's Medical Supply Chain function. This delivery order is issued under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $7,878.00 by the Defense Logistics Agency's Medical Supply Chain on August 5, 2025, for the supply of ENGERIX-B 20 MCG/ML syringes. This firm fixed-price delivery order, which carries an ultimate completion date of August 8, 2025, represents a discrete procurement action under the company's existing Indefinite Delivery Contract with DLA....
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $7,578.00 by the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML vaccines. The award carries no set-aside designation and has an ultimate completion date of July 30, 2025, with performance taking place at the vendor's Park Ridge, Illinois location. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,607.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, carries a firm fixed-price contract type with no set-aside designation. This delivery order is issued under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,908.50 for ENGERIX-B 20 MCG/ML vaccine on January 5, 2026. This delivery order was issued without a set-aside designation under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which represents a $30.3 billion acquisition strategy designed to supply...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,971.76 by the Defense Logistics Agency for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract utilizes firm fixed-price pricing with an ultimate completion date of September 19, 2025, and was awarded on September 18, 2025, with no set-aside designation applied. The place of performance is Park...
- This delivery order for $2,362.08 was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRN, a hepatitis B vaccine, to the Defense Logistics Agency (DLA) Medical Supply Chain. The order, placed under the DLA's SPE2DB program, has a firm fixed price and an ultimate completion date of July 12, 2024. DMS Pharmaceutical Group specializes in providing a wide range...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D325F094FDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,969.50 on May 30, 2025, for ENGERIX-B 20 MCG/ML syringes. This firm fixed-price delivery order, which is expected to be completed by June 4, 2025, was issued without a set-aside designation. The award is funded through the Medical Supply Chain division of the Defense Logistics Agency, reflecting the Department of Defense's ongoing need for hepatitis B vaccines to support military health facilities and personnel immunization requirements. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026. The parent contract, established under the SPE2DB program, enables the agency to procure a comprehensive range of pharmaceutical products, biologics, and medical consumables to support military healthcare operations worldwide. DMS Pharmaceutical Group's selection for this award demonstrates its established capacity as a critical supplier within the federal pharmaceutical supply chain, leveraging its extensive distribution capabilities and woman-owned small business status to serve the Department of Defense's medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 5/30/25 |